Downregulation of PHLDA1 was associated with poor prognosis, more advanced clinical stage, and decreased overall survival (OS), as shown by the analysis of Kaplan–Meier curves in breast cancer patients. This evidence concerns the gene PHLDA1 and breast carcinoma.